MedReleaf Corp is a Canada-based company which operates as a licensed producer of cannabis-based pharmaceutical products. The Company produces and sells its dried cannabis and cannabis oil products, including cannabis oil capsules. The Company produce an aggregate of up to 6,000 kilograms of dried cannabis and up to 1,760 kilograms of cannabis oil, and to sell and distribute within Canada an aggregate of up to 5,000 kilograms of dried cannabis, up to 1,319 kilograms of bottled cannabis oil, and up to 440 kilograms of encapsulated cannabis oil. The Company is an analytically-driven organization focused on patient care, scientific innovation, and advancing the understanding of the therapeutic benefits of cannabis.
Industry, Sector and Symbol:
- Market Cap: C$715.85 million
- Outstanding Shares: 90,385,000
- 50 Day Moving Avg: C$8.03
- 200 Day Moving Avg: C$8.23
- 52 Week Range: C$6.81 - C$9.65
- Trailing P/E Ratio: 0.49
- P/E Growth: 0.00
- Average Volume: 84,049 shs.
Frequently Asked Questions for MedReleaf Corp (TSE:LEAF)
What is MedReleaf Corp's stock symbol?
MedReleaf Corp trades on the Tornton Stock Exchange (TSX) under the ticker symbol "LEAF."
Where is MedReleaf Corp's stock going? Where will MedReleaf Corp's stock price be in 2017?
1 brokerages have issued 1 year target prices for MedReleaf Corp's shares. Their predictions range from C$13.00 to C$13.00. On average, they anticipate MedReleaf Corp's share price to reach C$13.00 in the next year. View Analyst Ratings for MedReleaf Corp.
Who are some of MedReleaf Corp's key competitors?
Some companies that are related to MedReleaf Corp include Aritzia (ATZ), CES Energy Solutions Corp (CEU), Cara Operations Ltd (CARA), Cascades (CAS), Enghouse Systems Limited (ENGH), First Majestic Silver Corp. (FR), MEG Energy Corp (MEG), Enerflex Ltd (EFX), Evertz Technologies Limited (ET), MAG Silver Corp (MAG), Cogeco (CGO), Sleep Country Canada Holdings (ZZZ), Secure Energy Services (SES), ATS Automation Tooling Systems (ATA), Altus Group Ltd (AIF), Fiera Capital Corp (FSZ), Interfor Corp (IFP) and Knight Therapeutics (GUD).
Who are MedReleaf Corp's key executives?
MedReleaf Corp's management team includes the folowing people:
- Eitan Popper, President
- Neil Closner, Chief Executive Officer, Executive Director
- Igor Gimelshtein, Chief Financial Officer, Corporate Secretary
- Angelo Fefekos, Vice President - Clinical Affairs and Quality Compliance
- Darren Karasiuk, Vice President - Strategy
- Ivan Latysh, Vice President - Information Technology
- Lloyd Mitchell Segal, Non-Executive Chairman of the Board
- Norma Beauchamp, Non-Executive Director
- Ronald Funk, Non-Executive Director
- Deborah E. Rosati, Non-Executive Director
How do I buy MedReleaf Corp stock?
Shares of MedReleaf Corp and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is MedReleaf Corp's stock price today?
MarketBeat Community Rating for MedReleaf Corp (TSE LEAF)MarketBeat's community ratings are surveys of what our community members think about MedReleaf Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of MedReleaf Corp stock can currently be purchased for approximately C$7.92.
Consensus Ratings for MedReleaf Corp (TSE:LEAF) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||C$13.00|
Analysts' Ratings History for MedReleaf Corp (TSE:LEAF)
(Data available from 8/17/2015 forward)
|6/14/2017||Eight Capital||Set Price Target||Buy||C$13.00|
Earnings History for MedReleaf Corp (TSE:LEAF)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for MedReleaf Corp (TSE:LEAF)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for MedReleaf Corp (TSE:LEAF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for MedReleaf Corp (TSE:LEAF)Insider Trades by Quarter for MedReleaf Corp (TSE:LEAF)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Headline Trends for MedReleaf Corp (TSE:LEAF)
Latest Headlines for MedReleaf Corp (TSE:LEAF)
MedReleaf Corp (LEAF) Chart for Thursday, August, 17, 2017